These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35094918)

  • 21. Computational linguistic analysis applied to a semantic fluency task to measure derailment and tangentiality in schizophrenia.
    Pauselli L; Halpern B; Cleary SD; Ku BS; Covington MA; Compton MT
    Psychiatry Res; 2018 May; 263():74-79. PubMed ID: 29502041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Expression of Anomalous Self-Experiences in Spontaneous Speech in Clinical High-Risk and Early-Course Psychosis Quantified by Natural Language Processing.
    Srivastava A; Selloni A; Bilgrami ZR; Sarac C; McGowan A; Cotter M; Bayer J; Spark J; Krcmar M; Formica M; Gwyther K; Hartmann J; Ellenberg E; Polari A; McGorry P; Shah JL; Yung AR; Mizrahi R; Corcoran CM; Cecchi GA; Nelson B
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Oct; 8(10):1005-1012. PubMed ID: 37414359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural language processing methods are sensitive to sub-clinical linguistic differences in schizophrenia spectrum disorders.
    Tang SX; Kriz R; Cho S; Park SJ; Harowitz J; Gur RE; Bhati MT; Wolf DH; Sedoc J; Liberman MY
    NPJ Schizophr; 2021 May; 7(1):25. PubMed ID: 33990615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational linguistic analysis applied to a semantic fluency task: A replication among first-episode psychosis patients with and without derailment and tangentiality.
    Ku BS; Pauselli L; Covington MA; Compton MT
    Psychiatry Res; 2021 Oct; 304():114105. PubMed ID: 34298424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
    Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
    Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
    Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
    JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the Social Functioning Scale modified for use in individuals at clinical high-risk for psychosis.
    Kuhney FS; Damme KSF; Ellman LM; Schiffman J; Mittal VA
    Schizophr Res; 2022 Oct; 248():246-253. PubMed ID: 36115189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Social impairment and social language deficits in children and adolescents with and at risk for psychosis.
    D'Angelo EJ; Morelli N; Lincoln SH; Graber K; Tembulkar S; Gaudet A; Gonzalez-Heydrich J
    Schizophr Res; 2019 Feb; 204():304-310. PubMed ID: 30077431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis.
    Sabb FW; van Erp TG; Hardt ME; Dapretto M; Caplan R; Cannon TD; Bearden CE
    Schizophr Res; 2010 Feb; 116(2-3):173-83. PubMed ID: 19861234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cognitive functions between first-episode schizophrenia patients, their unaffected siblings and individuals at clinical high-risk for psychosis.
    Chu AOK; Chang WC; Chan SKW; Lee EHM; Hui CLM; Chen EYH
    Psychol Med; 2019 Aug; 49(11):1929-1936. PubMed ID: 30226125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding Language Abnormalities and Associated Clinical Markers in Psychosis: The Promise of Computational Methods.
    Hitczenko K; Mittal VA; Goldrick M
    Schizophr Bull; 2021 Mar; 47(2):344-362. PubMed ID: 33205155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of emotion awareness and regulation on social functioning in individuals at clinical high risk for psychosis.
    Kimhy D; Gill KE; Brucato G; Vakhrusheva J; Arndt L; Gross JJ; Girgis RR
    Psychol Med; 2016 Oct; 46(14):2907-2918. PubMed ID: 27050714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing depression in youth at clinical high risk for psychosis: a comparison of three measures.
    DeVylder JE; Yang LH; Harkavy-Friedman JM; Azimov N; Walder DJ; Corcoran CM
    Psychiatry Res; 2014 Feb; 215(2):323-8. PubMed ID: 24370335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability of Andreasen's thought, language and communications disorder scale.
    Davis GC; Simpson DM; Foster D; Arison Z; Post M
    Hillside J Clin Psychiatry; 1986; 8(1):25-33. PubMed ID: 3744296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural Language Processing and Psychosis: On the Need for Comprehensive Psychometric Evaluation.
    Cohen AS; Rodriguez Z; Warren KK; Cowan T; Masucci MD; Edvard Granrud O; Holmlund TB; Chandler C; Foltz PW; Strauss GP
    Schizophr Bull; 2022 Sep; 48(5):939-948. PubMed ID: 35738008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive and negative thought disorder and psychopathology in childhood among subjects with adulthood schizophrenia.
    Ott SL; Roberts S; Rock D; Allen J; Erlenmeyer-Kimling L
    Schizophr Res; 2002 Dec; 58(2-3):231-9. PubMed ID: 12409163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical high-risk criteria of psychosis in 8-17-year-old community subjects and inpatients not suspected of developing psychosis.
    Schultze-Lutter F; Walger P; Franscini M; Traber-Walker N; Osman N; Walger H; Schimmelmann BG; Flückiger R; Michel C
    World J Psychiatry; 2022 Mar; 12(3):425-449. PubMed ID: 35433326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis.
    Santesteban-Echarri O; Liu L; Miller M; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Tsuang MT; Walker EF; Woods SW; Addington J
    Schizophr Res; 2022 Oct; 248():114-121. PubMed ID: 36030758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.